FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
FDA OKs Gattex for Short Bowel Syndrome
(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com